Fullmektig i Norge:
Org.nummer: 979993269
- Org.nummer:
- Foretaksnavn:
- Foretaksform:
- Næring:
-
Forretningsadresse:
Fullmektig i EP:
2016.04.26, DK 201600248
AARON KUCINSKI ET AL: "Reducing falls in Parkinson's disease: interactions between donepezil and the 5-HT 6 receptor antagonist idalopirdine on falls in a rat model of impaired cognitive control of complex movements", EUROPEAN JOURNAL OF NEUROSCIENCE., vol. 45, no. 2, 18 August 2016 (2016-08-18), pages 217-231, XP055382414, GB ISSN: 0953-816X, DOI: 10.1111/ejn.13354 (B1)
HENDERSON EMILY J ET AL: "Rivastigmine for gait stability in patients with Parkinson's disease (ReSPonD): a randomised, double-blind, placebo-controlled, phase 2 trial", LANCET NEUROLOGY, LANCET PUBLISHING GROUP, LONDON, GB, vol. 15, no. 3, 13 January 2016 (2016-01-13), pages 249-258, XP029415433, ISSN: 1474-4422, DOI: 10.1016/S1474-4422(15)00389-0 cited in the application (B1)
HERRIK KJARTAN F ET AL: "The 5-HT6receptor antagonist idalopirdine potentiates the effects of acetylcholinesterase inhibition on neuronal network oscillations and extracellular acetylcholine levels in the rat dorsal hippocampus", NEUROPHARMACOLOGY, PERGAMON PRESS, OXFORD, GB, vol. 107, 31 March 2016 (2016-03-31), pages 351-363, XP029602105, ISSN: 0028-3908, DOI: 10.1016/J.NEUROPHARM.2016.03.043 (B1)
JORN ARNT ET AL: "Lu AE58054, a 5-HT6 antagonist, reverses cognitive impairment induced by subchronic phencyclidine in a novel object recognition test in rats", INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, vol. 13, no. 08, 23 June 2010 (2010-06-23) , pages 1021-1033, XP055408768, Cambridge ISSN: 1461-1457, DOI: 10.1017/S1461145710000659 (B1)
WO-A2-02/078693 (B1)
KOSHY CHERIAN AJEESH ET AL: "Co-treatment with rivastigmine and idalopirdine reduces the propensity for falls in a rat model of falls in Parkinson's disease", PSYCHOPHARMACOLOGY, SPRINGER VERLAG, BERLIN, DE, vol. 236, no. 6, 4 January 2019 (2019-01-04), pages 1701-1715, XP036983495, ISSN: 0033-3158, DOI: 10.1007/S00213-018-5150-Y [retrieved on 2019-01-04] (B1)
US-A1- 2014 073 681 (B1)
WO-A2-00/12623 (B1)
K. A. CHUNG ET AL: "Effects of a central cholinesterase inhibitor on reducing falls in Parkinson disease", NEUROLOGY, vol. 75, no. 14, 5 October 2010 (2010-10-05), pages 1263-1269, XP055382666, US ISSN: 0028-3878, DOI: 10.1212/WNL.0b013e3181f6128c (B1)
Statushistorie
Hovedstatus | Beslutningsdato, detaljstatus |
---|---|
EP patent gjort gjeldende i Norge | EP patent besluttet gjeldende i Norge |
EP under behandling | Forespørsel om å gjøre EP patent gyldig er mottatt |
Korrespondanse
Dato
Type korrespondanse
Journal beskrivelse
|
---|
Innkommende
EP Publiseringsdokument fra EPO
|
Utgående
EP Registreringsbrev (3210) (PTEP3448430)
|
Innkommende, AR557044066
Søknadsskjema Patent
|
Innkommende
EP Publiseringsdokument fra EPO
|
Til betaling:
Betalingshistorikk:
Beskrivelse / Fakturanummer | Betalingsdato | Beløp | Betaler | Status |
---|---|---|---|---|
Årsavgift 9. avg. år (EP) expand_more expand_less | 2025.04.09 | 3710,0 | CPA GLOBAL LIMITED | Betalt og godkjent |
Årsavgift 9. avg. år (EP)
3710,0 = 1 X 3710,0
En ordre på saken er opprettet av: Supplier Payments (08.04.2025 07:27:39): Betalt |
||||
Årsavgift 8. avg. år (EP) | 2024.02.22 | 2550 | CPA GLOBAL LIMITED | Betalt og godkjent |
32307245 expand_more expand_less | 2023.07.05 | 5500 | BRYN AARFLOT AS | Betalt |
Valideringsgebyr EP-patent
5500 = 1 X 5500
|